Patent Foramen Ovale Closure in hospitalized stroke patients in the United: Is there a racial disparity?

Author(s):  
Alain Lekoubou
2015 ◽  
Vol 20 (5) ◽  
pp. 75-79 ◽  
Author(s):  
Yang-Yang Huang ◽  
Bei Shao ◽  
Xian-Da Ni ◽  
Jian-Ce Li ◽  
Xiao-Ting Niu ◽  
...  

1995 ◽  
Vol 25 (2) ◽  
pp. 145A ◽  
Author(s):  
Stefano De Castro ◽  
Domenico Cartoni ◽  
Sergio Beni ◽  
Monica Moschini Antinori ◽  
Francesco Pelliccia ◽  
...  

The Lancet ◽  
1988 ◽  
Vol 332 (8601) ◽  
pp. 11-12 ◽  
Author(s):  
M.W.I. Webster ◽  
H.J. Smith ◽  
D.N. Sharpe ◽  
A.M. Chancellor ◽  
D.L. Swift ◽  
...  

Stroke ◽  
2012 ◽  
Vol 43 (suppl_1) ◽  
Author(s):  
Yoshiaki Shimada

Background: The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial and/or venous thrombosis and recurrent fetal loss, and can be an independent risk factor for a first-ever ischemic stroke especially in young female patients. Patent foramen ovale (PFO) has been established as a cause of cryptogenic stroke. Atrial septal aneurysm (ASA) is associated with PFO. Until recently, the precise pathophysiology of APS as causing ischemic stroke has been essentially unknown. In the present study, we investigated the relationship between APS and potential embolic sources including PFO and ASA using transesophageal echocardiography (TEE). Methods: This study was a retrospective case series design. From July 2006 to June 2008, 120 patients with ischemic stroke who admitted to Juntendo University Hospital underwent TEE. In this study period, consecutive ischemic stoke patients diagnosed as APS based on the modified Sapporo criteria were enrolled and classified into APS group. Controls were selected among age- and gender-matched stroke patients without APS who also underwent TEE. We assessed clinical characteristics and presence of embolic sources including PFO and atrial septal aneurysm (ASA) between APS and Control groups. Results: Nine of ischemic stroke patients with APS and 41 controls were included. Primary APS was present in one patient (11.1%) of the APS group, and APS with SLE were found in eight patients (88.9%). There is no significant difference in age, risk factors for ischemic stroke, and MRI findings between two groups. The prevalence of PFO and ASA were significantly higher in APS group compared to Control group (89% vs 41%, P=0.027; 67% vs 20%, P=0.015, respectively). C reactive protein was relatively higher in APS group. Multiple logistic regression analysis showed that PFO (OR: 13.71; 95% CI: 1.01 to 185.62; P=0.049) and ASA (OR: 8.06; 95% CI: 1.17 to 55.59; P=0.034) were independently associated with the APS group. Conclusion: Atrial septal abnormalities including PFO and ASA are strongly associated with APS group, and could be potential embolic sources in ischemic stroke patients with APS.


2011 ◽  
Vol 104 (4) ◽  
pp. 298
Author(s):  
N. Keenan ◽  
E. Brochet ◽  
J.-M. Juliard ◽  
M. Malanca ◽  
C. Cueff de Monchy ◽  
...  

2019 ◽  
Vol 32 (10) ◽  
pp. 1366-1367
Author(s):  
Mohammad K. Mojadidi ◽  
Muhammad O. Zaman ◽  
Fabian Nietlispach ◽  
Jonathan M. Tobis ◽  
Bernhard Meier

2020 ◽  
Vol 41 (11) ◽  
pp. 3227-3233 ◽  
Author(s):  
David Giannandrea ◽  
◽  
Chiara Padiglioni ◽  
Paolo Eusebi ◽  
Anna Mengoni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document